BiotechTube
ACON Laboratories

ACON Laboratories

San Diego, United States· Est.
aconlabs.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

ACON Laboratories is a privately-held, commercial-stage diagnostics company with a 25+ year history of developing and manufacturing affordable diagnostic devices for global markets. The company operates a major FDA-registered manufacturing facility in Hangzhou, China and has a diversified portfolio including blood glucose monitoring, lateral flow rapid tests (notably the Flowflex brand for COVID-19/Flu/RSV), urinalysis strips, and molecular diagnostic kits. ACON leverages a hybrid business model of branded products and OEM/contract manufacturing, positioning itself as a cost-effective supplier in the competitive in-vitro diagnostics (IVD) landscape.

Infectious DiseaseMetabolic DiseaseOncologyAllergyUrology

Technology Platform

Vertically integrated manufacturer of lateral flow immunoassays, clinical chemistry assays, electrochemical sensors for glucose monitoring, and molecular diagnostic (PCR) kits. Core competency is cost-effective development and production at scale.

Opportunities

Growing global demand for affordable, multiplex point-of-care and home tests for respiratory diseases presents a significant near-term opportunity.
The large and persistent market for diabetes management and the expansion of diagnostic testing in veterinary medicine provide stable, long-term growth avenues.
Its contract manufacturing (OEM) capabilities allow it to capture value from the broader diagnostics industry's outsourcing trends.

Risk Factors

High dependence on a single manufacturing facility in China exposes the company to geopolitical, trade, and operational disruption risks.
The diagnostics market is intensely competitive, with pressure from both large multinationals and low-cost producers, threatening margins and market share.
Regulatory compliance is critical; any issues at its main plant could suspend key market access.

Competitive Landscape

ACON competes in the crowded in-vitro diagnostics market against giants like Abbott, Roche, Siemens Healthineers, and Danaher, as well as numerous specialized and generic manufacturers. Its primary competitive edge is its focus on affordability and reliable quality, targeting cost-conscious healthcare systems globally. In rapid tests, it competes with companies like QuidelOrtho, BD, and a plethora of direct-to-consumer brands.

More companies in Diagnostics & Precision Medicine →More companies in United States →